Wird geladen...
Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells
Bone metastases represent common long term complications of patients with breast cancer. Zoledronic acid, an amino-bisphosphonate and mevalonate pathway inhibitor, is an established agent for the treatment of bone metastases. Direct antitumor effects of zoledronic acid have been proposed in breast c...
Gespeichert in:
| Veröffentlicht in: | J Bone Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4723419/ https://ncbi.nlm.nih.gov/pubmed/26909293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2014.02.001 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|